Conference Study Group. Serum interleukin-6 levels can predict resistance to treatment of chronic hepatitis C infection with pegylated-interferon alpha 2b plus ribavirin
Conference Study Group. Serum interleukin-6 levels can predict resistance to treatment of chronic hepatitis C infection with pegylated-interferon alpha 2b plus ribavirin
复制标题
会议研究组。
DOI：
--
复制
发表时间：
2011
期刊：
影响因子：
1.2
通讯作者：
Watanabe M and the Ochanomizu-Liver
中科院分区：
文献类型：
--
作者：
Ueyama M;Nakagawa M;Sakamoto N;Onozuka I;Funaoka Y;Watanabe T;Nitta S;Kiyohashi K;Kitazume A;Murakawa M;Nishimura-Sakurai Y;Sekine-Osajima Y;Itsui Y;Azuma S;Kakinuma S;Watanabe M and the Ochanomizu-Liver
